Skip to main content

Advertisement

SpringerLink
Log in

Short-term efficacy of transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for hepatocellular carcinoma: comparison with conventional transarterial chemoembolization

  • Published:
Abdominal Radiology Aims and scope Submit manuscript

An Erratum to this article was published on 01 December 2016

Abstract

Purpose

This study aimed to compare the short-term efficacy of transarterial chemoembolization (TACE) with epirubicin-loaded superabsorbent polymer embolics (SAP) and conventional TACE in TACE-naïve patients with unresectable hepatocellular carcinoma (HCC).

Methods

Fifty consecutive patients (mean age, 72.8 years; hepatitis C, 46%; BCLC-A or B, 52% or 48%) treated with TACE with SAP during 2013–2015 and 55 consecutive patients (mean age, 71.8 years; hepatitis C, 40%; BCLC-A or B, 51% or 49%) treated with conventional TACE during 2011–2013 were evaluated. Safety evaluations were based on CTCAE ver. 4.0. Short-term efficacies, i.e., at 1 month after TACE, were assessed using the European Association for the Study of the Liver criteria. Overall survival rates were calculated using the Kaplan–Meier method. Short-term response markers were analyzed by univariate and multivariate analyses.

Results

There was no significant difference in the incidence of any grade of adverse events. The objective response rates were 50% and 62% in patients treated with TACE with SAP and with conventional TACE, respectively (P = 0.358). The overall survival rates were not significantly different (P = 0.810); the 1-year survival rates and the median survival time of the patients treated with TACE with SAP and with conventional TACE were 76% and 74%, and 18 months and 21 months, respectively. Overall survival was related to the short-term response. An alpha-fetoprotein level <1,000 ng/mL was a significant short-term response marker on multivariate analysis.

Conclusions

For TACE-naïve patients, TACE with SAP and conventional TACE had comparable safety and short-term efficacies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    Article  PubMed  PubMed Central  Google Scholar 

  2. Sieghart W, Hucke F, Peck-Radosavljevic M (2015) Transarterial chemoembolization: modalities, indication, and patient selection. J Hepatol 62:1187–1195

    Article  PubMed  Google Scholar 

  3. Llovet JM, Bruix J (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48(Suppl 1):S20–37

    Article  CAS  PubMed  Google Scholar 

  4. Bruix J, Llovet JM, Castells A, et al. (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27:1578–1583

    Article  CAS  PubMed  Google Scholar 

  5. Varela M, Real MI, Burrel M, et al. (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46:474–481

    Article  CAS  PubMed  Google Scholar 

  6. Osuga K, Hori S, Hiraishi K, et al. (2008) Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Interv Radiol 31:1108–1116

    Article  Google Scholar 

  7. Lewis AL, Taylor RR, Hall B, et al. (2006) Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 17:1335–1343

    Article  PubMed  Google Scholar 

  8. Guiu B, Schmitt A, Reinhardt S, et al. (2015) Idarubicin-loaded ONCOZENE drug-eluting embolic agents for chemoembolization of hepatocellular carcinoma: in vitro loading and release and in vivo pharmacokinetics. J Vasc Interv Radiol 26:262–270

    Article  PubMed  Google Scholar 

  9. Hong K, Khwaja A, Liapi E, et al. (2006) New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12:2563–2567

    Article  CAS  PubMed  Google Scholar 

  10. Malagari K, Chatzimichael K, Alexopoulou E, et al. (2008) Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Interv Radiol 31:269–280

    Article  Google Scholar 

  11. Poon RT, Tso WK, Pang RW, et al. (2007) A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol 5:1100–1108

    Article  CAS  PubMed  Google Scholar 

  12. Lammer J, Malagari K, Vogl T, et al. (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Interv Radiol 33:41–52

    Article  Google Scholar 

  13. Golfieri R, Giampalma E, Renzulli M, et al. (2014) Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma. Br J Cancer 111:255–264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. de Baere T, Plotkin S, Yu R, et al. (2016) An in vitro evaluation of four types of drug-eluting microspheres loaded with doxorubicin. J Vasc Interv Radiol 27:1425–1431

    Article  PubMed  Google Scholar 

  15. Osuga K, Khankan AA, Hori S, et al. (2002) Transarterial embolization for large hepatocellular carcinoma with use of superabsorbent polymer microspheres: initial experience. J Vasc Interv Radiol 13:929–934

    Article  PubMed  Google Scholar 

  16. de Luis E, Bilbao JI, de Ciercoles JA, et al. (2008) In vivo evaluation of a new embolic spherical particle (HepaSphere) in a kidney animal model. Cardiovasc Interv Radiol 31:367–376

    Article  Google Scholar 

  17. Grosso M, Vignali C, Quaretti P, et al. (2008) Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study. Cardiovasc Interv Radiol 31:1141–1149

    Article  Google Scholar 

  18. Seki A, Hori S, Kobayashi K, Narumiya S (2011) Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience. Cardiovasc Interv Radiol 34:557–565

    Article  Google Scholar 

  19. Dekervel J, van Malenstein H, Vandecaveye V, et al. (2014) Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up. J Vasc Interv Radiol 25(248–255):e241

    Google Scholar 

  20. Kucukay F, Badem S, Karan A, et al. (2015) A single-center retrospective comparison of doxorubicin-loaded HepaSphere transarterial chemoembolization with conventional transarterial chemoembolization for patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 26:1622–1629

    Article  PubMed  Google Scholar 

  21. Bruix J, Sherman M, Llovet JM, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430

    Article  CAS  PubMed  Google Scholar 

  22. Lencioni R, de Baere T, Burrel M, et al. (2012) Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations. Cardiovasc Interv Radiol 35:980–985

    Article  Google Scholar 

  23. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429–442

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hepatobiliary and Pancreatic Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, 241-8515, Japan

    Manabu Morimoto, Satoshi Kobayashi, Satoshi Moriya, Makoto Ueno, Shun Tezuka, Kuniyasu Irie, Yoshihiro Goda & Shinichi Ohkawa

Authors
  1. Manabu Morimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satoshi Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Satoshi Moriya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Makoto Ueno
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shun Tezuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kuniyasu Irie
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoshihiro Goda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shinichi Ohkawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manabu Morimoto.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study protocol was approved by the institutional ethics committee and complied with local laws and the Declaration of Helsinki.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

The original version of this article is revised. “Figure 2 was duplicated and placed incorrectly in place of Fig. 1. The correct version of Fig. 1 has been updated.”

An erratum to this article is available at http://dx.doi.org/10.1007/s00261-016-0999-x.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Morimoto, M., Kobayashi, S., Moriya, S. et al. Short-term efficacy of transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for hepatocellular carcinoma: comparison with conventional transarterial chemoembolization. Abdom Radiol 42, 612–619 (2017). https://doi.org/10.1007/s00261-016-0900-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-016-0900-y

Keywords

Search

Navigation